Shanghai Kehua Bio-Engineering Co Ltd (002022) - Total Liabilities

Latest as of March 2026: CN¥1.50 Billion CNY ≈ $218.93 Million USD

Based on the latest financial reports, Shanghai Kehua Bio-Engineering Co Ltd (002022) has total liabilities worth CN¥1.50 Billion CNY (≈ $218.93 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shanghai Kehua Bio-Engineering Co Ltd - Total Liabilities Trend (2001–2025)

This chart illustrates how Shanghai Kehua Bio-Engineering Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Shanghai Kehua Bio-Engineering Co Ltd (002022) investment intensity to see how much of total assets are deployed in long-term investments.

Shanghai Kehua Bio-Engineering Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shanghai Kehua Bio-Engineering Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
J.Kumar Infraprojects Limited
NSE:JKIL
India Rs28.28 Billion
Kenmec Mechanical Engineering Co Ltd
TWO:6125
Taiwan NT$5.97 Billion
Forward Air Corporation
NASDAQ:FWRD
USA $2.57 Billion
Plastika Kritis S.A.
AT:PLAKR
Greece €65.70 Million
Samhi Hotels Limited
NSE:SAMHI
India Rs20.08 Billion
Biglari Holdings Inc
NYSE:BH-A
USA $499.14 Million
Holcim Argentina SA
BA:HARG
Argentina AR$399.52 Billion
Moura Dubeux Engenharia S.A
SA:MDNE3
Brazil R$3.67 Billion

Liability Composition Analysis (2001–2025)

This chart breaks down Shanghai Kehua Bio-Engineering Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 002022 total assets.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.77 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.58 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.33 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Kehua Bio-Engineering Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Kehua Bio-Engineering Co Ltd (2001–2025)

The table below shows the annual total liabilities of Shanghai Kehua Bio-Engineering Co Ltd from 2001 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥1.53 Billion
≈ $224.16 Million
+22.18%
2024-12-31 CN¥1.25 Billion
≈ $183.46 Million
-31.25%
2023-12-31 CN¥1.82 Billion
≈ $266.84 Million
-38.42%
2022-12-31 CN¥2.96 Billion
≈ $433.31 Million
+62.35%
2021-12-31 CN¥1.82 Billion
≈ $266.90 Million
-12.23%
2020-12-31 CN¥2.08 Billion
≈ $304.09 Million
+104.87%
2019-12-31 CN¥1.01 Billion
≈ $148.43 Million
-5.53%
2018-12-31 CN¥1.07 Billion
≈ $157.12 Million
+68.70%
2017-12-31 CN¥636.48 Million
≈ $93.14 Million
+50.66%
2016-12-31 CN¥422.47 Million
≈ $61.82 Million
+22.11%
2015-12-31 CN¥345.97 Million
≈ $50.63 Million
+114.37%
2014-12-31 CN¥161.39 Million
≈ $23.62 Million
-0.43%
2013-12-31 CN¥162.08 Million
≈ $23.72 Million
-18.57%
2012-12-31 CN¥199.05 Million
≈ $29.13 Million
+13.17%
2011-12-31 CN¥175.89 Million
≈ $25.74 Million
+13.06%
2010-12-31 CN¥155.58 Million
≈ $22.77 Million
+16.95%
2009-12-31 CN¥133.03 Million
≈ $19.47 Million
+42.18%
2008-12-31 CN¥93.56 Million
≈ $13.69 Million
-25.84%
2007-12-31 CN¥126.16 Million
≈ $18.46 Million
+45.91%
2006-12-31 CN¥86.46 Million
≈ $12.65 Million
+13.29%
2005-12-31 CN¥76.32 Million
≈ $11.17 Million
+20.16%
2004-12-31 CN¥63.51 Million
≈ $9.29 Million
-22.84%
2003-12-31 CN¥82.31 Million
≈ $12.04 Million
+3.81%
2002-12-31 CN¥79.29 Million
≈ $11.60 Million
+115.22%
2001-12-31 CN¥36.84 Million
≈ $5.39 Million
--

About Shanghai Kehua Bio-Engineering Co Ltd

SHE:002022 China Medical Devices
Market Cap
$407.94 Million
CN¥2.79 Billion CNY
Market Cap Rank
#13380 Global
#3984 in China
Share Price
CN¥5.42
Change (1 day)
+2.46%
52-Week Range
CN¥4.58 - CN¥7.74
All Time High
CN¥29.42
About

Shanghai Kehua Bio-Engineering Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sale of in vitro diagnostic reagents and medical testing equipment and services in China and internationally. The company offers immunoassay and clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management solution, and automated co… Read more